Telix Pharmaceuticals | Brutto Fortjeneste På Salg



Gross Profit On Sales Endring Dato
Cochlear AUD 867.2M 38.9M 2024-06
CSL USD 3.34B 991M 2024-06
Ecofibre AUD 2.08M 4.33M 2024-06
Integral Diagnostics AUD 226.91M 7.04M 2024-06
Mayne Pharma AUD 115.99M 63.1M 2024-06
Medical Developments International AUD 13.36M 2.36M 2024-06
Mesoblast -6457000 3.1M 2024-06
Opthea USD 212.56K 300.45K 2024-06
Pacific Edge 283K 0 2024-03
Paradigm Biopharmaceuticals AUD 5.24M 3.96M 2024-06
Polynovo AUD 23.26M 22.74M 2024-06
PYC Therapeutics AUD 6.58M 2.13M 2024-06
Ramsay Health Care AUD 6.32B 20.5M 2024-12
ResMed USD 751.28M 34.06M 2024-12
Sonic Healthcare AUD 3.92B 3.14B 2024-12



Telix Pharmaceuticals Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.